Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Safety of INF904 for Patients with Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Germany Greece Poland
  • Study on the Effectiveness of AVTX-009 for Treating Moderate to Severe Hidradenitis Suppurativa in Patients

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia France Germany Greece Italy +3
  • Study on Long-term Effects of Secukinumab in Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Greece +8
  • Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    1 1 1
    Investigated drugs:
    Bulgaria France Germany Greece Ireland Italy +3
  • Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

    Not recruiting

    1 1
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +16
  • Study on Amlitelimab for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    France Germany Hungary Italy Poland Portugal +1
  • Study on the Effectiveness of Ianalumab for Treating Moderate to Severe Hidradenitis Suppurativa in Patients

    Not recruiting

    Investigated drugs:
    Austria Belgium France Germany Hungary Spain
  • Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    1 1 1
    Austria Belgium Bulgaria Czechia Denmark France +6
  • Study on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study

    Not recruiting

    1 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark Finland +8
  • Study of Eltrekibart for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    Investigated diseases:
    Germany Greece Poland